32 episodes

PeerView is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerView Neuroscience & Psychiatry CME/CNE/CPE Video Podcast PeerView Press

    • Science

PeerView is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

    • video
    Marwan Sabbagh, MD, FAAN, CCRI - Exploring Current Guidelines and Emerging Therapeutic Strategies for the Treatment of Dementia-Related Psychosis

    Marwan Sabbagh, MD, FAAN, CCRI - Exploring Current Guidelines and Emerging Therapeutic Strategies for the Treatment of Dementia-Related Psychosis

    Go online to PeerView.com/QCV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in dementia-related psychosis discusses current guidelines and emerging therapeutic strategies for the treatment of dementia-related psychosis. Upon completion of this activity, participants should be better able to: Employ established tools and current criteria to accurately recognize and diagnose psychosis in patients with dementia, Assess key data sets on the efficacy, safety, and tolerability of available and emerging treatment approaches for the management of dementia-related psychosis (DRP), Select individualized nonpharmacological and/or pharmacological treatments for DRP based on patients’ specific needs and circumstances.

    • 30 min
    • video
    Perry Shieh, MD, PhD, FAAN - Ensuring Optimal Management Throughout the Clinical Spectrum of Spinal Muscular Atrophy

    Perry Shieh, MD, PhD, FAAN - Ensuring Optimal Management Throughout the Clinical Spectrum of Spinal Muscular Atrophy

    Go online to PeerView.com/HNM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in neurology discusses SMA presentation and progression, the importance of early SMA diagnosis, treatments approved for SMA, recommendations for symptomatic care, and methods for supporting patients with SMA and their caregivers. Upon completion of this activity, participants should be better able to: Recognize the role of newborn screening in overcoming diagnostic delays in spinal muscular atrophy, Apply current data on the efficacy, safety, and tolerability of approved therapies for the treatment of spinal muscular atrophy from infancy through adulthood, Identify how symptomatic monitoring and support may evolve in patients with spinal muscular atrophy over the course of their disease, Employ symptomatic care in conjunction with approved treatments to optimize outcomes in patients with spinal muscular atrophy.

    • 48 min
    • video
    Victor C. Urrutia, MD, FAHA - Time Is of The Essence: Incorporating Recent Guideline Updates to Support Early Recognition and Management of Acute Ischemic Stroke

    Victor C. Urrutia, MD, FAHA - Time Is of The Essence: Incorporating Recent Guideline Updates to Support Early Recognition and Management of Acute Ischemic Stroke

    Go online to PeerView.com/GMR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, a panel of experts discusses current guideline-based recommendations and therapeutic interventions to accurately identify and appropriately manage patients with an acute ischemic stroke. Upon completion of this activity, participants should be better able to: Describe the burden of acute ischemic stroke according to current standards of care from the perspective of the patient and the healthcare system, Identify patients with salvageable brain tissue using newer imaging technologies consistent with recommendations in recently updated evidence-based guidelines, To improve management of acute ischemic stroke, determine appropriate candidates to initiate timely therapeutic interventions in patients with suspected stroke.

    • 54 min
    • video
    Gregory W. Albers, MD - Large Hemispheric Infarction: Exploring the Latest Clinical Advances in the Diagnosis and Treatment

    Gregory W. Albers, MD - Large Hemispheric Infarction: Exploring the Latest Clinical Advances in the Diagnosis and Treatment

    Go online to PeerView.com/NDJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, a stroke and vascular neurologist shares a patient case to provide clinical relevance and a practical exploration of the latest advances in the diagnosis and treatment of patients with a large hemispheric infarction (LHI). Upon completion of this activity, participants should be better able to: Apply current evidence-based guidelines to diagnose and treat patients with an LHI, Identify clinical characteristics associated with increased risk of cerebral edema in patients following an LHI, Summarize the benefits and limitations of current and emerging therapeutic strategies to prevent cerebral edema in patients following an LHI.

    • 31 min
    • video
    Diana Castro, MD - Great Expectations: Helping Patients With Spinal Muscular Atrophy and Their Families Understand Diagnosis and Treatment in a New Era of Therapy

    Diana Castro, MD - Great Expectations: Helping Patients With Spinal Muscular Atrophy and Their Families Understand Diagnosis and Treatment in a New Era of Therapy

    Go online to PeerView.com/HWV860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert discusses the diagnosis and treatment of spinal muscular atrophy in a new era of therapy. Upon completion of this activity, participants should be better able to: Employ current recommendations for screening and diagnosis of patients suspected to have spinal muscular atrophy (SMA), Recognize clinical signs and symptoms associated with early manifestations of SMA from birth to adulthood, Apply current data on the efficacy, safety, and tolerability of approved disease-modifying therapies for SMA from infancy through adulthood, Counsel patients and/or their parents/caregivers regarding the need for ongoing supportive care to optimize treatment outcomes.

    • 36 min
    • video
    Stephen Krieger, MD, FAAN / Clyde E. Markowitz, MD - Navigating the Evolving Management Paradigm Across Multiple Sclerosis Phenotypes in the Age of Potential Prognostic and Predictive Biomarkers

    Stephen Krieger, MD, FAAN / Clyde E. Markowitz, MD - Navigating the Evolving Management Paradigm Across Multiple Sclerosis Phenotypes in the Age of Potential Prognostic and Predictive Biomarkers

    Go online to PeerView.com/EQK860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, based on a live symposium recently held in West Palm Beach, Florida, leading experts on multiple sclerosis (MS) dive into the latest data on approved and emerging therapies for relapsing and progressive forms of MS and offer practical strategies to improve patient management, treatment selection, and outcomes. In addition to exploring the treatment armamentarium for MS, the panel considers the prognostic and predictive utility of serum neurofilament light chain as an emerging biomarker, including how it may affect disease-modifying treatment selection and sequencing. Upon completion of this activity, participants should be better able to: Apply current data on approved and emerging disease-modifying therapies for the treatment of relapsing forms of MS, Employ recent data related to available and investigational therapies for the treatment of progressive forms of MS, Assess available data on the potential prognostic and predictive utility of serum neurofilament light chain levels in patients with MS, Develop strategies based on clinical phenotypes, goals, preferences, and potential biomarker findings when selecting disease-modifying therapies for patients with MS.

    • 51 min

Top Podcasts In Science

Listeners Also Subscribed To

More by PeerView Press